Acorai

Acorai is developing a device for heart failure management through non-invasive intracardiac pressure monitoring (ICPM), to help reduce hospitalizations and readmissions. Our product, The Acorai Heart Monitor, can monitor mean pulmonary artery pressure (mPAP) non-invasively through a machine learning analysis of pressure dynamics in acoustics, vibratory and waveform data. Our technology show compelling precision, has a low-risk clinical and regulatory pathway, a low dependence on reimbursement and a fast track to commercialization. With a team with more than 50 years of industry experience, we can help heart failure patients live longer, healthier, and less uncertain lives. Acorai was founded in 2019 and is headquartered in Skane, Sweden.